Huddly AS
OSE:HDLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Huddly AS
OSE:HDLY
|
NO |
|
Radius Health Inc
NASDAQ:RDUS
|
US |
|
Atlantis Glory Inc
OTC:AGLY
|
CN |
|
Grand Field Group Holdings Ltd
HKEX:115
|
HK |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Canggang Railway Ltd
HKEX:2169
|
CN |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SZSE:002287
|
CN |
Cash Flow Statement
Cash Flow Statement
Huddly AS
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
101
|
(183)
|
(199)
|
(225)
|
(332)
|
(76)
|
(86)
|
(42)
|
(59)
|
(75)
|
(107)
|
(123)
|
(136)
|
(172)
|
(190)
|
(172)
|
(184)
|
(151)
|
(141)
|
|
| Depreciation & Amortization |
43
|
47
|
52
|
57
|
64
|
48
|
46
|
53
|
63
|
45
|
61
|
65
|
42
|
63
|
60
|
61
|
61
|
61
|
63
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
262
|
0
|
0
|
24
|
6
|
6
|
7
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
2
|
237
|
246
|
251
|
285
|
50
|
6
|
15
|
(6)
|
28
|
28
|
4
|
8
|
19
|
25
|
26
|
36
|
20
|
20
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
12
|
11
|
16
|
18
|
19
|
17
|
16
|
16
|
|
| Change in Working Capital |
(13)
|
6
|
(16)
|
(44)
|
4
|
(23)
|
42
|
(53)
|
(61)
|
(123)
|
(94)
|
(57)
|
(7)
|
20
|
(10)
|
(30)
|
(28)
|
(37)
|
(19)
|
|
| Cash from Operating Activities |
132
N/A
|
107
-19%
|
83
-22%
|
40
-52%
|
22
-46%
|
(3)
N/A
|
8
N/A
|
(27)
N/A
|
(63)
-131%
|
(126)
-101%
|
(111)
+12%
|
(112)
-1%
|
(93)
+17%
|
(71)
+24%
|
(115)
-63%
|
(115)
+0%
|
(115)
0%
|
(107)
+7%
|
(77)
+29%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(8)
|
(8)
|
(9)
|
(6)
|
(17)
|
(80)
|
(70)
|
(82)
|
(85)
|
(100)
|
(123)
|
(76)
|
(69)
|
(71)
|
(68)
|
(69)
|
(71)
|
(75)
|
(76)
|
|
| Other Items |
(52)
|
(56)
|
(61)
|
(67)
|
(76)
|
(37)
|
(73)
|
4
|
(51)
|
0
|
0
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Cash from Investing Activities |
(61)
N/A
|
(64)
-6%
|
(69)
-8%
|
(72)
-4%
|
(94)
-30%
|
(62)
+34%
|
(89)
-44%
|
(78)
+12%
|
(85)
-9%
|
(49)
+42%
|
(72)
-47%
|
(73)
-2%
|
(65)
+11%
|
(68)
-4%
|
(65)
+4%
|
(64)
+1%
|
(67)
-5%
|
(71)
-6%
|
(72)
-1%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
1
|
284
|
284
|
283
|
283
|
(45)
|
(45)
|
(40)
|
0
|
0
|
0
|
122
|
150
|
150
|
150
|
150
|
145
|
145
|
203
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
(18)
|
(23)
|
(29)
|
(6)
|
38
|
40
|
40
|
13
|
(5)
|
(4)
|
(3)
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(3)
|
(5)
|
(10)
|
(14)
|
(15)
|
(16)
|
(14)
|
(14)
|
(15)
|
|
| Cash from Financing Activities |
1
N/A
|
284
+25 712%
|
284
+0%
|
283
0%
|
283
+0%
|
(56)
N/A
|
(52)
+7%
|
(59)
-13%
|
(20)
+66%
|
(29)
-48%
|
(9)
+69%
|
155
N/A
|
179
+15%
|
177
-1%
|
148
-16%
|
129
-13%
|
127
-2%
|
127
+0%
|
188
+48%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
10
|
0
|
0
|
0
|
10
|
18
|
13
|
15
|
2
|
(5)
|
(2)
|
(4)
|
|
| Net Change in Cash |
72
N/A
|
326
+351%
|
298
-9%
|
251
-16%
|
211
-16%
|
(121)
N/A
|
(133)
-10%
|
(153)
-15%
|
(167)
-9%
|
(203)
-22%
|
(191)
+6%
|
(20)
+90%
|
39
N/A
|
52
+32%
|
(17)
N/A
|
(48)
-184%
|
(61)
-27%
|
(54)
+12%
|
36
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
124
N/A
|
99
-20%
|
75
-24%
|
34
-54%
|
4
-88%
|
(82)
N/A
|
(63)
+24%
|
(109)
-74%
|
(147)
-35%
|
(226)
-53%
|
(234)
-4%
|
(189)
+19%
|
(161)
+14%
|
(142)
+12%
|
(183)
-29%
|
(183)
0%
|
(186)
-2%
|
(183)
+2%
|
(152)
+17%
|
|